Sandra Mancilla Zamora Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups. Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Sandra Mancilla Zamora LinkedIn Twitter Orcid Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.
Degrees: Stable animal experimentation course. ABC function in 2020 Senior Clinical Analysis Technician in 2005 Higher Techniques in Pathological Anatomy and Cytology in 2001. Currently Vall d'Hebron University Hospital. VHIR-CIBBIM. FVPR since 01/11/2017 Technician in charge of the histology section of FVPR and the DDT group of the VHIR. With knowledge in environment and quality management at ISO 9001. Application management, internal positions… They also carry out research with various projects where I am in charge of the processing of the samples, making blocks, cuts, stains, immune. I give assistance the in vitro section (cell culture) and molecular biology techniques (western blot, enzymatic activities ...) and the in vivo section helping to prepare treatments, subcutaneous, intravenous cell inoculation, mammary, control of mice’s evolution, weight, tumor size, etc., necropsies and collection of biological samples for further processing. Responsible for the control of own equipment, maintenance, verification and calibration. Order control and organization of the general laboratory.
Projects Mejora del tratamiento de las enfermedades de depósito lisosomal mediante vehículos nanométricos optimizados. IP: - Collaborators: Sandra Mancilla Zamora, Mejora del tratamiento de las enfermedades de depósito lisosomal mediante vehículos nanométricos optimizados. , Mejora del tratamiento de las enfermedades de depósito lisosomal mediante vehículos nanométricos optimizados. , Diana Fernandes de Rafael Funding agency: Instituto de Salud Carlos III Funding: 116160 Reference: PI18/00871 Duration: 01/01/2019 - 30/06/2022 SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.. IP: - Collaborators: SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Olga Sánchez- Maroto Carrizo, Sandra Mancilla Zamora, SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Belen Garcia Prats, SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Maria Fidel Lledò, SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Diana Fernandes de Rafael, Simon Schwartz Navarro Funding agency: EUROPEAN COMMISSION Funding: 649580 Reference: SAFE-N-MEDTECHEC_H2020-NMBP2018 Duration: 01/04/2019 - 30/09/2023 Smart-4-Fabry: Smart multifunctional GLA-nanoformulation for Fabry disease IP: - Collaborators: Simon Schwartz Navarro, Sandra Mancilla Zamora, Smart-4-Fabry: Smart multifunctional GLA-nanoformulation for Fabry disease Funding agency: EUROPEAN COMMISSION Funding: 266300.8 Reference: SMART4FABRY_H2020NMBP2016 Duration: 01/01/2017 - 31/12/2020 NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy IP: Simon Schwartz Navarro Collaborators: Joaquin Seras Franzoso, NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy , Sandra Mancilla Zamora, NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy , Olga Sánchez- Maroto Carrizo Funding agency: EUROPEAN COMMISSION Funding: 630633.55 Reference: NOCANTHER_H2020NMP2015 Duration: 01/04/2016 - 30/09/2021 Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3
